BRCA1-Like Triple Negative Tumors: Clinicopathological Variables and Chemosensitivity to Alkylating Agents

被引:0
|
作者
Wesseling, J. [1 ]
Lips, E. H. [1 ]
Oonk, A. M. M. [1 ]
Smits, R. M. [1 ]
van Rijn, C. C. M. [1 ]
Mulder, L. [1 ]
Laddach, N. [1 ]
Savola, S. S. [1 ]
Wessels, L. F. A. [1 ]
Nederiof, P. M. [1 ]
Rodenhuis, S. [1 ]
Imholz, A. L. T. [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
关键词
D O I
10.1158/0008-5472.SABCS11-PD03-08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PD03-08
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer.
    Rodriguez, A. A.
    Rimawi, M.
    Wu, M-F
    Dave, B.
    Wong, H.
    Landis, M.
    Cairo, M.
    Pavlick, A.
    Froehlich, A.
    Chamness, G.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Osborne, C. K.
    Chang, J.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 509S - 509S
  • [2] Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy
    Miquel-Cases, Anna
    Steuten, Lotte M. G.
    Retel, Valesca P.
    van Harten, Wim H.
    [J]. BREAST, 2015, 24 (04): : 397 - 405
  • [3] EARLY STAGE COST-EFFECTIVENESS ANALYSIS OF A BRCA1-LIKE TEST TO DETECT TRIPLE NEGATIVE BREAST CANCERS RESPONSIVE TO HIGH DOSE ALKYLATING CHEMOTHERAPY
    Cases, Miquel A.
    Steuten, L. M. G.
    Retel, V. P.
    van Harten, W. H.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A323 - A323
  • [4] Characterisation of distinct subgroups of BRCA1-like triple-negative breast cancers with multiomics data analysis
    Chan, T. W. S.
    Opdam, M.
    Schouten, P.
    De Boo, L.
    Hilbers, F. S.
    Linn, S. C.
    De Menezes, R. X.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S592 - S593
  • [5] BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium
    Severson, Tesa
    Peeters, Justine
    Majewski, Ian
    Bosma, Astrid
    Chin, Suet-Feung
    Caldas, Carlos
    Simon, Iris
    Bernards, Rene
    Linn, Sabine
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [6] BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
    Severson, Tesa M.
    Peeters, Justine
    Majewski, Ian
    Michaut, Magali
    Bosma, Astrid
    Schouten, Philip C.
    Chin, Suet-Feung
    Pereira, Bernard
    Goldgraben, Mae A.
    Bismeijer, Tycho
    Kluin, Roelof J. C.
    Muris, Jettie J. F.
    Jirstrom, Karin
    Kerkhoven, Ron M.
    Wessels, Lodewyk
    Caldas, Carlos
    Bernards, Rene
    Simon, Iris M.
    Linn, Sabine
    [J]. MOLECULAR ONCOLOGY, 2015, 9 (08) : 1528 - 1538
  • [7] Identification of basal-like carcinomas in clinical practice: "triple zero/BRCA1-like" carcinomas
    Vincent-Salomon, A.
    Macgrogan, G.
    Charaffe-Jauffret, E.
    Jacquemier, J.
    Arnould, L.
    [J]. BULLETIN DU CANCER, 2010, 97 (03) : 357 - 363
  • [8] Lack of HIN-1 methylation in BRCAl-linked and "BRCA1-like" breast tumors
    Krop, I
    Maguire, P
    Lahti-Domenici, J
    Lodeiro, G
    Richardson, A
    Johannsdottir, HK
    Nevanlinna, H
    Borg, A
    Gelman, R
    Barkardottir, RB
    Lindblom, A
    Polyak, K
    [J]. CANCER RESEARCH, 2003, 63 (09) : 2024 - 2027
  • [9] Characterization of the BRCA1-like immunoreactivity of human seminal plasma
    Angelopoulou, K
    Borchert, G
    Melegos, DN
    Lianidou, E
    Lilja, H
    Diamandis, EP
    [J]. UROLOGY, 1999, 54 (04) : 753 - 762
  • [10] Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study
    Eva Gross
    Harm van Tinteren
    Zhou Li
    Sandra Raab
    Christina Meul
    Stefanie Avril
    Nadja Laddach
    Michaela Aubele
    Corinna Propping
    Apostolos Gkazepis
    Manfred Schmitt
    Alfons Meindl
    Petra M. Nederlof
    Marion Kiechle
    Esther H. Lips
    [J]. BMC Cancer, 16